Table 3.

Percent of patients with aNSCLC with progression noted in their chart 1, 2, and 3 months before their NGS test, stratified by time of NGS test.

	% patients with progression prior to test
Timing of NGS test, after advanced diagnosisa	0–1 mo before	1–2 mo before	2–3 mo before
6–9 months	46.46	16.16	9.43
9–12 months	48.63	21.96	13.33
12–15 months	44.80	23.98	14.48

^aAdvanced NSCLC diagnosis refers to the diagnosis of stage IIIB or IV disease, or the diagnosis of a recurrence (progression) of initial early-stage disease; this differs from the initial diagnosis, which refers to the earliest diagnosis for NSCLC, regardless of stage at that moment.